Tumefactive fibroinflammatory lesion of the maxilla: Successful resection and microvascular reconstruction after failed medical therapy-Reference-Cited by-同舟云学术

Tumefactive fibroinflammatory lesion of the maxilla: Successful resection and microvascular reconstruction after failed medical therapy

Published:2020-10-31 Issue: Volume: Page:
ISSN:1865-1550
Container-title:Oral and Maxillofacial Surgery
language:en
Short-container-title:Oral Maxillofac Surg

Author:

Higginson James,Breik Omar^ORCID,Goodrum Heather,Warfield Adrian,Bates Timothy,Rhodes Benjamin,Martin Timothy

Publisher

Springer Science and Business Media LLC

Subject

Otorhinolaryngology,Oral Surgery,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10006-020-00914-y.pdf

Reference15 articles.

1. Patel PC, Pellitteri PK, Vrabec DP, Szymanski M (1998) Tumefactive fibroinflammatory lesion of the head and neck originating in the infratemporal fossa. Am J Otolaryngol 19:216–219. https://doi.org/10.1016/S0196-0709(98)90092-8

2. Laurenzo JF, Graham SM (1995) Tumefactive fibroinflammatory lesion of the head and neck: a management strategy. Ear Nose Throat J 74(2):87–94. https://doi.org/10.1177/014556139507400207

3. Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192. https://doi.org/10.1038/modpathol.2012.72

4. Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH, for the American College of Rheumatology/European League Against Rheumatism IgG4‐Related Disease Classification Criteria Working Group, Akamizu T, Akiyama M, Barra L, Bateman A, Blockmans D, Brito-Zeron P, Campochiaro C, Carruthers M, Chari S, Chiba T, Choi H, Cornell L, Culver E, Darabian S, Torre ED, Deshpande V, Dong L, Ebbo M, Fernández-Codina A, Ferry JA, Fragkoulis G, Frost F, Frulloni L, Hart PA, Hernandez-Molina G, Inoue D, Ji H, Keat K, Kamisawa T, Kawa S, Kawano M, Khosroshahi A, Kobayashi H, Kodama Y, Kubo S, Kubota K, Lanzillotta M, Leng H, Lerch M, Liu Y, Liu Z, Löhr M, Martin-Nares E, Martinez-Valle F, Marvisi C, Masaki Y, Matsui S, Mizushima I, Naden RP, Nakamura S, Nordeide J, Notohara K, Okazaki K, Paira S, Perugino CA, Popovic J, Ramos-Casals M, Rosenbaum J, Ryu J, Saeki T, Sato Y, Schleinitz N, Sekiguchi H, Sharma A, Sokol EV, Stone JR, Stone JH, Sun W, Takahashi H, Takahashi N, Takahira M, Tanaka Y, Umehara H, Vaglio A, Villamil A, Wada Y, Wallace ZS, Webster G, Yamada K, Yamamoto M, Yi J, Yi Y, Zamboni G, Zen Y, Zhang W (2020) The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7–19. https://doi.org/10.1002/art.41120

5. Kusaka S, Nishimura S, Kawakami F, Ohbayashi C, Shibuya Y, Iwata K (2013) Tumefactive fibroinflammatory lesion presenting with head and neck fibrosclerosing lesions and orbital pseudotumors: a case report. J Med Case Rep 7:260. https://doi.org/10.1186/1752-1947-7-260

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Tumefactive Fibroinflammatory Lesion of the Head and Neck Mimicking Immunoglobulin G4-related Disease;Internal Medicine;2023-02-15

2. Tumefactive fibroinflammatory lesion of the head and neck;Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology);2023

3. Cyclophosphamide/rituximab/prednisolone;Reactions Weekly;2021-07